Pharma TV Ad Spending Trends + AI Algorithm for Heart Disease – Xtalks Life Science Podcast Ep. 11

In this episode, Ayesha discusses the latest trends in pharma tv ad spending, including the top spenders last week. The pandemic has led to a rise in both TV watching and health awareness, which pharma companies took advantage of by increasing spending on TV commercials by about 17 percent overall. Last week, three of the top ten TV ads by expenditure were from pharma, which included GLP-1 diabetes drugs Rybelsus and Trulicty and the anti-inflammatory Dupixent for treating eczema.

The group also talked about a new AI algorithm developed by researchers at the Mayo Clinic that can help increase the identification and diagnosis of cases of low ejection fraction. Low ejection fraction is often asymptomatic in early stages and hence goes underdiagnosed in many instances. The new AI algorithm is integrated into routine electrocardiograms (ECG), which are fast and readily accessible but cannot diagnose the condition on their own. The team discussed the promise of integrating AI approaches into existing medical tools and technologies to facilitate enhanced diagnoses and treatments.